IPHA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Innate Pharma SA

Watchlist Manager

Watchlist

Price: 2.27 USD 2.95% Market Closed

Market Cap: $183.8m

	Innate Pharma SA NASDAQ:IPHA	FR
	Fine Foods & Pharmaceuticals NTM SpA MIL:FF	IT
M	Memiontec Holdings Ltd SGX:TWL	SG
D	Delta Air Lines Inc F:OYC	US
S	Saintmed PCL SET:SMD	TH
A	Azorim Investment Development and Construction Co Ltd TASE:AZRM	IL
N	Nordic Unmanned ASA OSE:NUMND	NO
	PhaseBio Pharmaceuticals Inc OTC:PHASQ	US
N	Nusantara Inti Corpora Tbk PT IDX:UNIT	ID
F	Full Circle Lithium Corp XTSX:FCLI	CA
	B&M European Value Retail SA LSE:BME	LU
	America Great Health OTC:AAGH	US

Profitability Summary

Innate Pharma SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

62%

Declining Gross Margin

93% > 1%

Negative Operating Margin

-1 834%

Negative 3Y Average Operating Margin

-653%

Declining Operating Margin

-152% > -1 834%

Negative Net Margin

-1 765%

Negative 3Y Average Net Margin

-615%

Declining Net Margin

-144% > -1 765%

Negative Free Cash Flow Margin

-1 898%

Negative 3Y Average Free Cash Flow Margin

-559%

Declining Free Cash Flow Margin

-74% > -1 898%

Exceptional ROE

764%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-254%

Declining ROIC

-55% > -835%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.